FibroGen (FGEN) Tops Q3 EPS by 21c

FibroGen (NASDAQ: FGEN) reported Q3 EPS of ($0.38), $0.21 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $30.1 million versus the consensus estimate of $24.3 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Wolfe upgrades AT&T to Outperform as improving fundamentals outweigh Starlink risk
• Origin Bancorp, Inc. (OBK) Tops Q2 EPS by 9c
• First Mid Bancshares, Inc. (FMBH) Tops Q2 EPS by 24c